Dataset from A Multicenter, Double-blind, Randomized, Clinical Study to Assess the Efficacy and Safety of Intravenous S-649266 in Complicated Urinary Tract Infections With or Without Pyelonephritis or Acute Uncomplicated Pyelonephritis Caused by Gram-Negative Pathogens in Hospitalized Adults in Comparison With Intravenous Imipenem/Cilastatin

The purpose of this study was to determine the efficacy and safety of intravenous cefiderocol
(S-649266) in hospitalized adults with complicated urinary tract infections caused by
Gram-negative pathogens.